Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by bionicjoeon Jun 15, 2019 1:50pm
59 Views
Post# 29829066

RE:RE:RE:RE:RE:RE:RE:RE:200,000 Warrants Converted

RE:RE:RE:RE:RE:RE:RE:RE:200,000 Warrants ConvertedIt must be frustrating bencro when after 6 years of posting and thousands of man hours molding a rosy concept for the science the market still won't reward you in term of the sp. You said it yourself many times that the market is waiting on the data. For me that data is anything beyond 6 months after a patient's initial treatment and in a respectable sized group as per FDA protocol.

You recently stated that the sp will take off once the 3 month data from the phase 2 trial is released. I don't see that happening since it has already been acertained in the phase 1b trial that efficacy can be expected at the 3 month juncture. As for whether the FDA will require a phase 3 trial, who knows for sure? They may ask one be held to see how effective the treatment is beyond the 12 month period should enough patients exhibit favorable results. Phase 3 trials are by no means rare.

Your Walmart Chinese crystal ball has predicted many times in the past that meeting a certain condition would result in a sp in the multiple of dollars yet while you hide in your scientific journals the sp continues to not respond. Chuck that useless piece of glass in the trash bin and start doing DD the proper way with reality as your main focus or is it just a new name but the same old bencro? And please don't accuse me of saying something I didn't say.
Bullboard Posts